Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.
about
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsLevetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the StriatumStriatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movementsEmerging preclinical pharmacological targets for Parkinson's diseaseStriatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonismThe neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexesStriatal glutamate release in L-DOPA-induced dyskinetic animalsAdaptive gene regulation in the Striatum of RGS9-deficient micePSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor traffickingCell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy.Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia.Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalingCell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice.Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned ratsEnhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian miceTargeting the dopamine D3 receptor: an overview of drug design strategies.Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB ExpressionRegion-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonismActivation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.Prospects of statins in Parkinson diseaseDeciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling.Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's diseaseGlutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine.Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's diseaseImpact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesiaControlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats.Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism.A new knock-in mouse model of l-DOPA-responsive dystonia.Modulation of striatal projection systems by dopamine.Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model.
P2860
Q21129423-072DE702-2077-4F77-A93C-34F5C784B15FQ21284508-AF9F8373-494C-46E5-A07E-9D555CEFB225Q24632752-A31545EE-F484-440F-B104-88484FA0982BQ26764724-29B6172F-EC09-4203-991B-0201A7A3CFBDQ26768220-B5428224-2254-4B35-A0B7-BAD1395793F0Q27313903-5029E35F-AA95-436F-AD74-7D1E320761D3Q28289714-FA2BCAD0-6179-49F9-A364-416B1E473490Q28485942-4E5EDB64-2F94-4FC9-8806-06DA05E318D8Q28541409-C51B4EB6-ED12-4AF8-9B22-B887D318EB1FQ28582674-A51BB349-76C3-4024-A16B-A005034AB8BBQ30650489-F421BF44-3A5D-47F4-B5C2-EAF7B076B50CQ30836713-F15E3354-BD64-468D-86BB-C7FFA1F9B52DQ30988635-03B1B97A-F94E-42B5-AEB5-F2922E71B6D0Q33428476-026805CD-C208-4CB3-9325-9B0623894630Q33723034-64610C50-32CE-4B3C-948E-9400DB39FAE5Q33758221-DA9600D0-0BAF-4EA3-BD6A-4B8C89F8352EQ34044620-7EB3E2C5-2EF4-4A30-A8E6-B5FF0B42CF65Q34094008-D83436B8-AC10-4314-A072-4BE461366DCDQ34482483-5E99A0DE-4163-437E-8661-391D3F800F7BQ34490801-7824C221-F632-4464-A6DE-295C3A11152FQ34524556-E55A7F9E-8A6F-4B23-A144-190F35F5ED3DQ35000569-66217ABC-0308-4B08-ABB8-5CA60320D9B6Q35024117-0869879E-4B88-4B7F-9FE2-AF64C4AC16FEQ35028568-E1339239-9431-4E01-A43E-808D3331C67CQ35070472-A85B5D65-C8BD-43B8-ABC2-A1842790A343Q35094028-B1087C97-0D19-4BB5-A4F7-ADF6D4A3CC9AQ35106605-6A1A3F89-656E-4BEF-AEE6-BAF44C8B4E17Q35116470-C88D7AFE-1973-46D3-A670-330C3B60D010Q35124773-965F9B84-79D4-4434-8991-8A125A45C1ABQ35208420-9568923D-2209-42EA-B3F8-BDD4AB1383F8Q35324207-C3F868C4-90F9-4F3C-8D48-0671A0AFD648Q35605023-92118622-FB5D-4D57-9039-D1F63752F9F5Q35683102-2540B24E-BDDB-4EC5-A061-0BA0E8CD9D83Q35738538-AFD16DDC-B7F4-4767-ABDA-10E573DEE6B0Q35777273-5349E786-2354-42BA-B868-1055B37135EEQ35972575-FE837C36-6CD0-41EC-B6E3-22D46AF39AB1Q36201811-981AC14C-CB2E-417D-8A8A-E30D690D5328Q36232197-A49CDED7-A4AE-4E5C-81ED-D980D18A94F9Q36367283-28E433AB-BCF5-475F-8021-26AE373F4710Q36662702-18F3C9C3-6B6E-4089-97D5-68738BBD31D2
P2860
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Spatiotemporal pattern of stri ...... role of dopamine D1 receptors.
@ast
Spatiotemporal pattern of stri ...... role of dopamine D1 receptors.
@en
type
label
Spatiotemporal pattern of stri ...... role of dopamine D1 receptors.
@ast
Spatiotemporal pattern of stri ...... role of dopamine D1 receptors.
@en
prefLabel
Spatiotemporal pattern of stri ...... role of dopamine D1 receptors.
@ast
Spatiotemporal pattern of stri ...... role of dopamine D1 receptors.
@en
P2093
P2860
P921
P1476
Spatiotemporal pattern of stri ...... role of dopamine D1 receptors
@en
P2093
Christine Konradi
Elissa M Strome
Linda Vercammen
M Angela Cenci
P2860
P304
P356
10.1016/J.BIOPSYCH.2006.11.032
P407
P50
P577
2007-07-26T00:00:00Z